Opus Genetics (IRD) Shares Outstanding (2010 - 2026)

Opus Genetics (IRD) has 11 years of Shares Outstanding (Entity) data on file, last reported at $1.1 million in Q3 2020.

• On a quarterly basis, Shares Outstanding (Entity) rose 11.55% year-over-year to $1.1 million in Q3 2020; TTM through Sep 2020 was $1.1 million, a 11.55% increase from a year earlier, with the FY2019 full-year figure at $1.0 million, up 28.52% from the prior year.
• Shares Outstanding (Entity) for Q3 2020 stood at $1.1 million, up from $1.0 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for IRD reached as high as $1.1 million in Q3 2020 and fell as low as $444094.0 in Q1 2016.
• Historically, Shares Outstanding (Entity) has averaged $744716.8 across 5 years, with a median of $661316.0 in 2018.
• Across the five-year window, Shares Outstanding (Entity) jumped 51.94% in 2019 and changed 0.0% in 2020, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $494499.0 in 2016, then jumped by 33.65% to $660913.0 in 2017, then rose by 18.29% to $781790.0 in 2018, then rose by 28.52% to $1.0 million in 2019, then gained by 11.55% to $1.1 million in 2020.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $1.1 million in Q3 2020, $1.0 million in Q2 2020, and $1.0 million in Q1 2020.